Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Vote In favor of Your Favored Language Interpretation Administration - 2ISS astronaut evacuation shouldn't interfere with upcoming Artemis 2 moon mission, NASA chief says
- 3The Universe of Impeccable Pearls: A Manual for Valuable Gems
- 45 Great and High Evaluated Scene Configuration Administrations For 2024
- 5Qantas and Virgin Australia Ban Power Bank Usage on Flights Following Safety Incidents
- I'm a woman who's into weightlifting. Was I man enough for the creatine-packed 'Man Cereal'?
- Manual for Big name Work out schedules
- The most effective method to Promoter for Cellular breakdown in the lungs Mindfulness in Your People group
- Step by step instructions to Recognize the Distinction Between Lab Jewels and Precious stone Simulants
- Step by step instructions to Pick the Right Sunlight powered charger Type for Your Home
- Texas cities have some of the highest preterm birth rates in the US, highlighting maternal health crisis nationwide
- Research highlights potential dangers of ultra-processed foods for women under 50 regarding precancerous polyps
- EU waters down plans to end new petrol and diesel car sales by 2035
- Fact Check: Some Bridge Photos Circulating Do NOT Show The Hongqi Bridge That Collapsed In Southwest China Nov. 11, 2025
